This platform will play an important part of Boehringer Ingelheim’s broader strategy to capture translational disease insights from large external healthcare biobanks and ultimately to accelerate the development of innovative medicines.
%20(1).png?width=540&height=631&name=mobile_bg_header_1%20(1)%20(1).png)
Genomic
Data
Clinical
Variables
Annotations
Real-World
Data
Sensor
Data
Phenotypic
Variables
Imaging
Data
EHR
Data
Multi-omics
Data
Transform
your organisation
Data
Align your data landscape & research needs, shape your data acquisition strategy & realise the potential of your data.
Infrastructure
Blueprinted, future-proofed infrastructure giving you the competitive advantage. Your federated architecture & cloud specialists.
Science
From Nextflow to advanced federated AI – answer your research questions by building simple, yet powerful, workflows in the language of your choice.
Commercial
Become part of the world’s largest federated network, gain competitive advantage & create commercially sustainable solutions.
How our platform has helped others
Dr. Jan Nygaard Jensen
SVP & Global Head of Computational Biology & Digital Sciences
SVP & Global Head of Computational Biology & Digital Sciences
The advanced capabilities of Lifebit’s Trusted Research Environment, coupled with our focus to reimagine the infrastructure of cancer care, will enable us to unlock the potential of cancer data.
Dr. Arun Sujenthiran
UK Clinical Lead and Senior Medical Director
UK Clinical Lead and Senior Medical Director
I am incredibly excited that Lifebit and AWS joined us to launch the next phase of our research capabilities.
Chris Wigley
CEO of Genomics England
CEO of Genomics England
